SCHEMBL6288189

SCHEMBL6288189

CCCCCC(O)C(O)CCC

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 2/20 0.58
LMNA P02545 3/20 0.54
CYP2D6 P10635 2/20 0.54
GMNN O75496 1/20 0.54
POLB P06746 1/20 0.54
THPO P40225 1/20 0.54
MTOR P42345 1/20 0.54
BLM P54132 1/20 0.54
KDM4E B2RXH2 1/20 0.54
TP53 P04637 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
MAPT P10636 1/20 0.54
CETP P11597 1/20 0.54
HTT P42858 1/20 0.54
UBE2N P61088 1/20 0.54
GPR84 Q9NQS5 7/20 0.46
FFAR1 O14842 1/20 0.46
OPRM1 P35372 1/20 0.43
FDPS P14324 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30787284 0.97 SPHK1 (0.62) SPHK1LMNACYP2D6GMNNPOLB
SCHEMBL30787152 0.97 SPHK1 (0.62) SPHK1LMNACYP2D6GMNNPOLB
SCHEMBL22418865 0.97 SPHK1 (0.62) SPHK1LMNACYP2D6GMNNPOLB
SCHEMBL17253452 0.97 SPHK1 (0.62) SPHK1LMNACYP2D6GMNNPOLB
SCHEMBL14666485 0.97 SPHK1 (0.62) SPHK1LMNACYP2D6GMNNPOLB
SCHEMBL30787316 0.97 SPHK1 (0.62) SPHK1LMNACYP2D6GMNNPOLB
SCHEMBL30787166 0.97 SPHK1 (0.62) SPHK1LMNACYP2D6GMNNPOLB
SCHEMBL9194535 0.97 SPHK1 (0.62) SPHK1LMNACYP2D6GMNNPOLB
SCHEMBL30787300 0.97 SPHK1 (0.62) SPHK1LMNACYP2D6GMNNPOLB
SCHEMBL1295728 0.94 SPHK1 (0.64) SPHK1LMNACYP2D6GMNNPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6899753-B2 Highly bleed-alleviating ink composition BENQ CORPORATION (TW) 2005-05-31 US claimed
US-20030037700-A1 Highly bleed-alleviating ink composition MIND FUSION, LLC 2003-02-27 US claimed
CN-119031839-A Compositions comprising an antimicrobial agent and an alkyl ketal ester compound 西姆莱斯股份公司 2024-11-26 CN disclosed
WO-2023210781-A1 ION EXCHANGE MEMBRANE, MEMBRANE ELECTRODE ASSEMBLY, CELL FOR REDOX FLOW BATTERIES, AND REDOX FLOW BATTERY 旭化成株式会社 2023-11-02 WO disclosed
US-11466041-B2 Process for preparing methyl phosphinic acid butyl ester ADAMA AGAN LTD. (IL) 2022-10-11 US disclosed
CN-107073516-B Method for producing structure having concave pattern, resin composition, method for forming conductive film, electronic circuit, and electronic device JSR株式会社 2020-09-15 CN disclosed
CN-105143977-B Method for producing substrate having concave pattern, composition, method for forming conductive film, electronic circuit, and electronic device JSR株式会社 2020-01-07 CN disclosed
US-10392699-B2 Method for manufacturing structure having recessed pattern, resin composition, method for forming electroconductive film, electronic circuit, and electronic device JSR CORPORATION (JP) 2019-08-27 US disclosed
WO-2018154385-A1 PROCESS FOR PREPARING METHYL PHOSPHINIC ACID BUTYL ESTER ADAMA AGAN LTD. (IL) 2018-08-30 WO disclosed
US-20170306481-A1 METHOD FOR MANUFACTURING STRUCTURE HAVING RECESSED PATTERN, RESIN COMPOSITION, METHOD FOR FORMING ELECTROCONDUCTIVE FILM, ELECTRONIC CIRCUIT, AND ELECTRONIC DEVICE JSR CORPORATION (JP) 2017-10-26 US disclosed
US-9746775-B2 Method for manufacturing substrate having concave pattern, composition, method for forming conductive film, electronic circuit and electronic device JSR CORPORATION (JP) 2017-08-29 US disclosed
CN-104022072-A Method for forming metal film, conductive ink, multilayer wiring board, semiconductor substrate, and capacitor cell JSR CORP 2014-09-03 CN disclosed
CN-103897494-A Copper film forming composition, copper film forming method, copper film, wiring substrate and electronic device JSR CORP 2014-07-02 CN disclosed
US-20140107350-A1 Process for Preparing Episulfide Compounds ASAHI KASEI CHEMICALS CORPORATION (JP) 2014-04-17 US disclosed
EP-2700636-A1 PROCESS FOR PREPARING EPISULFIDE COMPOUNDS Asahi Kasei Chemicals Corporation (JP) 2014-02-26 EP disclosed
CN-101519552-B Method for preparing inkjet water-soluble ink containing noble metal nano particles CHINESE ACAD INST CHEMISTRY 2011-08-24 CN disclosed
CN-101519552-A Method for preparing inkjet water-soluble ink containing noble metal nano particles CHINESE ACAD INST CHEMISTRY 2009-09-02 CN disclosed
US-6899753-B2 Highly bleed-alleviating ink composition BENQ CORPORATION (TW) 2005-05-31 US disclosed
CN-1401710-A Ink composition with high ink bleeding prevention BENQ CORP (CN) 2003-03-12 CN disclosed
US-20030037700-A1 Highly bleed-alleviating ink composition MIND FUSION, LLC 2003-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11466041-B2 Process for preparing methyl phosphinic acid butyl ester GLUL, PHOSPHO1, MPHOSPH6 SPHK1 1703/4885LMNA 3586/4885CYP2D6 1645/4885
US-20140107350-A1 Process for Preparing Episulfide Compounds TST, EPHX2, STS SPHK1 2147/4885LMNA 3658/4885CYP2D6 115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.